Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

E.W. Scripps (SSP) Asset Writedowns and Impairment (2017 - 2023)

E.W. Scripps (SSP) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $13.6 million as the latest value for Q1 2023.

Quarterly Asset Writedowns and Impairment changed N/A to $13.6 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $13.6 million through Mar 2023, changed N/A year-over-year, with the annual reading at $19.5 million for FY2025, N/A changed from the prior year.
Asset Writedowns and Impairment for Q1 2023 was $13.6 million at E.W. Scripps, up from $7.0 million in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $13.6 million in Q1 2023, with the low at $7.0 million in Q1 2021.